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ABSTRACT
Introduction: The microcirculation is the physiological
site of oxygen and substrate exchange. Its effectiveness
during circulatory shock is vital for the perfusion of
tissues, and has a bearing on subsequent organ
function and prognosis. Microcirculatory dysfunction
following traumatic haemorrhagic shock (THS) has
been understudied compared with other pathologies
such as sepsis. The aim of the MICROSHOCK study is
to investigate changes seen in the microcirculation of
patients following THS, and to assess its response to
resuscitation. A greater understanding of the behaviour
and mechanisms of microcirculatory dysfunction in this
context may direct future avenues of goal-directed
resuscitation for these patients.
Methods and analysis: This multicentre prospective
longitudinal observational study includes patients who
present as an emergency with THS. Microcirculatory
parameters are recorded using sublingual incident dark
field microscopy alongside measurements of global flow
(oesophageal Doppler and transthoracic
echocardiography). Patients are enrolled into the study
as soon as feasible after they arrive in hospital, and then
at subsequent daily time points. Blood samples are
taken for investigation into the mechanisms of
microcirculatory dysfunction. Sequential Organ Failure
Assessment scores will be analysed with
microcirculatory parameters to determine whether they
correlate with greater fidelity than more conventional,
global circulatory parameters.
Ethics and dissemination: Research Ethics
Committee approval has been granted for this study
(Reference: 14/YH/0078). Owing to the nature of THS,
capacity for informed consent will be absent on patient
enrolment. This will be addressed according to the
Mental Health Capacity Act 2005. The physician in
charge of the patient’s care (nominated consultee) may
consent on behalf of the patient. Consent will also be
sought from a personal consultee (close relative or
friend). After capacity is regained, the participant will be
asked for their consent. Results will be submitted for
publication in peer-reviewed journal format and
presented at relevant academic meetings.
Trial registration number: NCT02111109;
Pre-results.
BACKGROUND
Massive haemorrhage and associated shock is
a leading cause of preventable death among
casualties with severe traumatic injury,
accounting for around 40–50% of all
deaths.1 2 Despite signiﬁcant improvements
in treatment and mortality within this patient
group, systemic inﬂammatory response, coa-
gulopathy and subsequent multiple organ
failure remain common.3 These issues can
lead to prolonged periods of morbidity, crit-
ical care dependency and often death.
Therapeutic interventions that attenuate
these responses may lead to signiﬁcant
beneﬁt for patients who have suffered trau-
matic haemorrhagic shock (THS).3
The microcirculation is of particular clin-
ical importance during circulatory shock
Strengths and limitations of this study
▪ This study’s main strength is that it will be the
largest clinical investigation into the microcircu-
latory response to traumatic injury and haemor-
rhagic shock to date.
▪ The MICROSHOCK study will recruit from major
trauma centres in London and Birmingham, the
two largest cities in the UK.
▪ The study is limited by its observational nature.
However, the key research question ‘Does the
microcirculatory behaviour predict outcome
better than global haemodynamic parameters?’
can be addressed using observational data.
▪ A further limitation is the heterogeneous nature
of injury patterns in the UK trauma patient popu-
lation. Such differences will be addressed during
data analysis, and reported during the dissemin-
ation of the results. These differences will be
much greater than those in animal studies.
However, a clinical study allows us to translate
what has been learnt from animal research into
useful and clinically relevant knowledge.
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since it is this network of capillaries and other small
vessels that perform the essential functions of delivering
oxygen and substrates to cells. Traditionally, resuscitative
strategies are guided by measurement of global haemo-
dynamic parameters such as blood pressure and cardiac
output. However, there may be a poor correlation
between such global parameters and the appearance of
the microcirculation.4 5 Microcirculatory parameters
may also predict outcome better than more conven-
tional global circulatory measurements in sepsis.6
Observational data suggest patients who can improve
the state of the microcirculation in response to resusci-
tative ﬂuid therapy have a better outcome than those
who cannot.7 8
Incident dark ﬁeld (IDF) video microscopy is a
method of assessing the microcirculation that has
been developed relatively recently for clinical and
research.9 A light source is applied to the tissue,
which illuminates the deep tissues within the target
ﬁeld. The reﬂected light from the deep tissues is
captured and magniﬁed before being received on a
viewer. The selective wavelength of transmitted light is
completely absorbed by both oxygenated and deoxy-
genated haemoglobin, and blood vessels therefore
appear black. The technique is limited to organs that
have a thin epithelial covering and that are accessible
to a handheld probe, which in clinical practice has
usually been the sublingual microcirculation. The
device is small, portable and the technique
non-invasive. Obtaining images with the device
requires between 2 and 5 min and involves the use of
a small, non-traumatic sublingual probe. The images
produced by IDF microscopy require ofﬂine analysis
and the ascription of objective values before they can
be used. De Backer et al10 have standardised this
approach.
Most clinical studies that examine the microcircula-
tion have focused on sepsis,7 11 12 whereas studies
relating to haemorrhagic shock are mostly limited to
animal experiments, and have usually looked at con-
trolled haemorrhagic shock rather than a complex
traumatic injury model.13–15 One clinical study has
examined the microcirculation after THS once the
patients had been admitted to the intensive care unit
(ICU), but did not gather data during the early
phases of resuscitation.16 Although they share similar-
ities, septic and haemorrhagic shock must be exam-
ined separately in a clinical context, so that their
respective differences can be delineated, and
unanswered questions can be addressed.
Primary objective
The primary objective of the MICROSHOCK study is to
examine the microcirculatory function in patients follow-
ing THS, and to determine whether these parameters
are superior to global haemodynamic parameters in the
prediction of clinical outcomes.
METHODS
Study design
This is a multicentre prospective longitudinal observa-
tional study that involves serial assessments of the sublin-
gual microcirculation alongside measurements of global
ﬂow, volume status and blood pressure, determined
from existing monitoring devices and using focused
transthoracic echocardiography. In conjunction, data
will be gathered relating to the patients physiology and
resuscitation.
Patient screening
All patients with a history of traumatic injury presenting
to the emergency department (ED) at the study site hos-
pitals will be screened by research staff. These sites are
all UK Major Trauma Centres, and include (1) Kings
College Hospital, London, UK; (2) The Royal London
Hospital, London, UK; and (3) Queen Elizabeth
Hospital Birmingham, Birmingham, UK. Patient details
will be recorded in a screening log.
Number of patients
A single pilot study demonstrated feasibility in the exam-
ination of the microcirculation following THS, and
reported data for 18 patients.16 The current study will be
the ﬁrst to examine the microcirculation of patients with
THS as soon as they have arrived in the ED. The
MICROSHOCK study will enrol 60 patients in order to
further investigate the microcirculation following THS,
and form hypotheses that might direct future goal-
directed interventions.
Inclusion criteria
Adult patients with evidence of haemorrhagic shock
exhibiting all of the following features:
1. Mechanism of injury consistent with blood loss;
2. Intubated and ventilated;
3. Serum lactate concentration >2 mmol/L recorded at
any stage prior to admission to the ICU;
4. Have received any blood products (eg, packed red
blood cells (PRBC), fresh frozen plasma (FFP), cryo-
precipitate, platelets) during the initial period of
resuscitation, prior to admission to ICU, or are pre-
dicted to receive blood products during this time-
frame in the opinion of the trauma team leader.
Exclusion criteria
Patients with facial injuries, where access to the sublin-
gual area would be problematic will be excluded.
Patients with injuries deemed unsurvivable in whom the
focus of care is palliation rather than active treatment
are also ineligible for inclusion.
Time points and techniques for data collection
Figure 1 outlines the techniques that will be utilised,
samples taken and data collected at each time point.
There are ﬁve main time points:
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1. As soon as feasible after arrival in hospital (T1), and
up to every 60 min until haemodynamically stable;
2. On admission to ICU (D0);
3. 24 h after D0;
4. 48 h after D0;
5. 72 h after D0.
Where feasible, and appropriate, further readings will
be taken between the ﬁrst and second time points. Data
collection is stopped once the patient has been
extubated.
Demographic and resuscitation data
The following baseline (hospital admission) demo-
graphic and physiological data will be collected from
study participants and recorded in an electronic data-
base on a secure encrypted computer used only for
research purposes. All data in this log will be anon-
ymised and assigned a sequential study number.
▸ Demographic details (age, gender, ethnicity);
▸ Mechanism of injury;
▸ Injury Severity Score (ISS);
▸ Admission systolic blood pressure (SBP), respiratory
rate and Glasgow Comas Scale (GCS; to calculate
Trauma and Injury Severity (TRISS) score);
▸ Administered prestudy blood products and intraven-
ous ﬂuids;
▸ Timings from injury to start of prehospital resuscita-
tion, ED resuscitation and operating theatre-based
resuscitation;
▸ Nature of initial surgical procedures and treatments.
Acquisition of IDF images
The investigator will obtain video clips of the sublingual
microcirculation using an IDF videomicroscope
(Cytocam, Braedius Medical B.V., Huizen, The
Netherlands). In accordance with international consen-
sus criteria for assessing the microcirculation, enough
video will be recorded to enable at least three (and pref-
erably ﬁve) ×10 s video clips to be obtained at each time
point. Because the microcirculation can demonstrate
considerable heterogeneity, particularly in shock states,
images will be acquired from different sites within the
sublingual area. When acquiring images, investigators
should actively seek to minimise pressure artefact by
observing ﬂow in medium and large vessels. The image
should be stabilised with minimal movement artefact.
Light intensity and focus should be optimised.
Individual video sequences will be exported from the
image acquisition software as DV-AVI ﬁles.
Acquisition of transthoracic echo images
Subcostal and apical ﬁve-chamber windows will be
obtained. The inferior vena cava will be visualised in M
mode, and the minimum and maximum diameters
across the respiratory cycle recorded. The left ventricular
outﬂow tract (LVOT) will be visualised and a pulsed
wave Doppler signal acquired. The LVOT velocity time
integer (VTi) and the degree of variation across the
respiratory cycle will both be recorded.
Figure 1 Sampling and techniques. BP, blood pressure; ED, emergency department; GCS, Glasgow Comas Scale; ICU,
intensive care unit; IDF, incident dark field; HR, heart rate; RR, respiratory rate.
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Oesophageal Doppler
An oral oesophageal Doppler probe (Deltex Medical,
Chichester, UK) will be inserted at the same time as
acquisition of the ﬁrst IDF images. The probe will
remain in situ continuously for 72 h or until the patient
is ready for extubation. The following data will be
recorded: corrected ﬂow time, stroke volume, cardiac
output. Data obtained from this monitoring device will
also be available for use to the patients’ attending clini-
cians if they wish.
Thromboelastography (ROTEM)
A 5 ml sample of blood will be withdrawn from existing
vascular access devices and used to perform
point-of-care analysis of coagulation status using the
technique of thromboelastography (ROTEM). The fol-
lowing values will be recorded: EXTEM/FIBTEM CFT,
A5, A10, MCF, LY 30.
Biological sampling
Samples of blood and urine will be withdrawn from exist-
ing vascular access devices and stored for later assessment
of the mechanisms of microcirculatory dysfunction.
Physiological and pharmacological data
The following parameters will also be recorded at every
time point where available:
▸ SBP, diastolic blood pressure and mean arterial blood
pressure;
▸ Central venous pressure;
▸ Heart rate;
▸ Arterial Blood Gas Data (including lactate, base
deﬁcit, arterial oxygen saturation, arterial carbon
dioxide saturation)
▸ Haemoglobin concentration;
▸ Central Venous Blood Gas Data (central venous
oxygen saturation (ScvO2), central venous carbon
dioxide saturation (ScvCO2));
▸ Plasma (free) haemoglobin;
▸ Administration of blood, blood products and bolus
challenges of other intravenous ﬂuids since the previ-
ous time point;
▸ Type of sedative drug infusions currently being
administered;
▸ Type and dose of inotropic and vasopressor drugs
currently being administered.
Primary outcome
The primary outcome is the Sequential Organ Failure
Assessment (SOFA) score at the D3 time point (72 h after
admission to ICU), and will be recorded using information
from the patients’ charts and laboratory results.
Secondary outcomes
Secondary outcomes include SOFA scores and multior-
gan dysfunction score on days 1, 7 and 28 of hospital
admission (if the patient is still an inpatient), mortality
at 28 days, length of stay (LOS) in hospital, LOS in ICU,
number of days of mechanical ventilation,
thromboelastography parameters, arterial and venous
blood gas parameters, and blood product requirements.
Analysis of IDF video sequences
Prior to analysis, the recorded video sequences will be
edited into at least three (and no more than ﬁve) video
clips. All clips will be rated for quality using a ﬁve-point
scale.17 Substandard images will be rejected. All IDF images
will be analysed using a dedicated software tool
(Automated Vascular Analysis V.3.02, Microvision Medical,
The Netherlands). This is a semiautomated process which
produces a number of data points from the video sequence.
Analysis of the video clips will produce the following data:
▸ Microvascular ﬂow index;
▸ Total vessel density;
▸ Perfused vessel density;
▸ Proportion of perfused vessels
▸ Microcirculatory heterogeneity index.
This process is in accordance with recommendations
made by an international consensus conference on
assessing the microcirculation.10 Interobserver variation
will be tested at regular intervals in order to minimise
heterogeneity of data analysis between investigators. At
the time of analysis, the investigators will be blinded
with respect to the clinical time point of the study, the
patients’ details, and the other outcome variables (SOFA
score and haemodynamic data).
The following relationships will be examined:
▸ Between microcirculatory parameters during the post-
resuscitation period and the development of SOFA
scores;
▸ Between microcirculatory parameters and systemic
haemodynamic data (stroke volume, cardiac output,
blood pressure);
▸ Between microcirculatory parameters and plasma
lactate and ScvO2 over the resuscitation period;
▸ Between microcirculatory parameters and coagulation
parameters as assessed by ROTEM.
Capacity and consent
This study complies with the Declaration of Helsinki,
and will be conducted in accordance with the principals
of Good Clinical Research Practice (GCP). In order to
assess the response of the microcirculation to haemor-
rhagic shock and resuscitation, intubated and ventilated
patients will be recruited to the study at an early stage
following their admission to hospital, when capacity for
informed consent will be absent.
Lack of patient capacity will be addressed by referring
to the Mental Health Capacity Act (2005). In this situ-
ation, the physician in charge of the care of the patient
(nominated consultee) will be consulted in order to
consent on behalf of the patient. These physicians will
have received prior brieﬁng on the study protocol, and
will not be a study investigator. If possible consent will
also be sought from a personal consultee (the next of
kin, relative or friend of the patient). When the patient
regains capacity, the study will be explained and the
4 Hutchings S, et al. BMJ Open 2016;6:e010893. doi:10.1136/bmjopen-2015-010893
Open Access
participant asked for their consent to use the data col-
lected so far, as well as any further samples required by
the protocol. If the participant declines consent and
wishes to be removed from the study, their data will be
erased and no further samples will be collected.
Patients who die or who do not regain capacity within
28 days of injury will have their data entered into the
study in accordance with the wishes of their personal or
nominated consultee. This process is summarised in
ﬁgure 2.
Confidentiality, data storage and security
All data relating to study participants will be treated in
accordance with the Data Protection Act, 1998. All study
data will be stored on a secure encrypted laptop used
exclusively by the study investigators. Patients will be
assigned an alphanumeric sequential study number that
will be used to identify all clinical data. These numbers
will be speciﬁc to each site. The patients’ demographic
details will be linked to the study number on a separate
screening database held on the secure computer at each
site. Individual IDF image sequences will be assigned a
random ﬁve-digit number. Identiﬁcation of these video
sequences will be achieved by cross-reference with an
electronic database. On completion of the study, all par-
ticipant identifying information and other study data will
be securely archived in accordance with the policy of the
sponsoring institution. All biological samples will be
Figure 2 Process flow chart.
Hutchings S, et al. BMJ Open 2016;6:e010893. doi:10.1136/bmjopen-2015-010893 5
Open Access
identiﬁable only by study number, and once analysis is
complete the samples will be disposed off.
Safety
The chief investigator has overall responsibility for the
conduct of the study including responsibility for safety.
Individual investigators will be responsible for reporting
all serious adverse events (SAEs) and adverse events
(AEs) to the chief investigator. There are no reported
AEs associated with the use of IDF imaging in the pub-
lished literature, and the risk of harm occurring to a
study participant as a direct result of undergoing IDF
imaging is close to zero. An example of an attributable
AE would be a sublingual haematoma following IDF
microscopy. SAEs will include death, any event which
poses a threat to life, prolongs hospital stay or produces
signiﬁcant disability. Given the nature of the study popu-
lation, it is anticipated that such features will be rela-
tively common as part to the pathological process of
trauma, but not as a result of participation in the study.
The chief investigator will review all events to decide if
there is any causal link. If this is the case action will be
taken in accordance with the principals of ICH GCP.
Statistical analysis
Normally distributed data will be presented as mean and
SD, and non-normally distributed data will be presented as
median and IQR. For comparison, patients will be dichoto-
mised according to day 3 SOFA score into those with a
score ≥6 versus those with SOFA score <6. The score of 6
has been chosen due to its prognostic relevance18 and pre-
vious utilisation as an end point for haemorrhagic trauma
patients.16 Further analysis will be conducted according to
the change in SOFA scores between days 1 and 3, so that
patients are dichotomised into SOFA score ‘improvers’ and
‘non-improvers’. This approach has also been used as an
end point for haemorrhagic trauma patients.19 Groups will
be compared using a two-tailed t test for normally distribu-
ted data and the Mann-Whitney U test for non-normally
distributed data. A p value of <0.05 will be considered statis-
tically signiﬁcant.
DISCUSSION
Bedside point-of-care technology that enables direct visu-
alisation of the microcirculation offers an opportunity to
gain insight into the real-time behaviour of the site of
oxygen and nutrition exchange during shock. Although
this has been primarily been a research tool in the past,
advances in microcirculatory imaging may pave the way
for a future clinical role.20 In particular because real-
time assessment of images by clinicians may be as reli-
able as detailed ofﬂine computer analysis.21
Further research into bedside microcirculatory
imaging, and the assessment of microcirculatory para-
meters as end points for resuscitation have been recom-
mended by other investigators.22 The current study aims
to address important questions with regard to the
microcirculation during THS. Of particular interest is to
investigate any immediate microcirculatory derangement
on arrival in hospital following traumatic haemorrhagic
injury, and whether there is a relationship between these
changes and clinical outcomes. It is also not fully known
whether there is a persistent microcirculatory derange-
ment following initial resuscitation, and whether there is
a relationship between this and subsequent organ dys-
function. Only one clinical study has reported such a
ﬁnding,16 but this was a relatively small study, with high
usage of vasopressors, which is a relatively uncommon
practice in the UK. Further data are required in order
to fully answer this research question. If there is a true
lack of coherence between macro haemodynamic para-
meters (eg, cardiac output and blood pressure) when
compared with microcirculatory parameters, then this
may strengthen the argument to improve techniques
and technology to enable bedside microcirculatory mon-
itoring. The results of this study will be examined with
these clinical questions in mind.
Trauma patients are heterogeneous, with multiple con-
founding variables that make interpretation of data more
difﬁcult than an animal model may offer. Nevertheless, a
clinical study is both timely and necessary in order to start
the process of translating what has been learnt from
animal research into useful and clinically relevant knowl-
edge. The Microshock study will be the ﬁrst to enrol
patients with THS as soon as they arrive in hospital.
Measuring microcirculatory parameters this soon after
injury offers an opportunity to gain a greater insight into
the early processes and mechanisms of microcirculatory
dysfunction in this context. If clinically relevant details are
discovered, then this may enable future investigators to
determine the priorities and processes that may be put in
place to move the technology towards clinical utilisation.
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